Vitamin K in combination with other biochemical markers to diagnose osteoporosis

References

• BIKLE, D. D. 1997, Biochemical markers in the assessment of bone disease. American Journal of Medicine, 103, 427–436.
   PubMed Web of Science ®Google Scholar
• CHRiscim IFS, E., SHIREMAN, T. and WALLACE, R. 1994, Costs and health effects of osteoporotic fractures. Bone, 15, 377–386.
   PubMed Web of Science ®Google Scholar
• CHRISTENSON, R H. 1997, Biochemical markers of bone metabolism: an overview. Clinical Biochemistry, 30, 573–593.
   PubMed Web of Science ®Google Scholar
• DAMBACHER, M. A. and RUEGSEGGER, P. 1994, Bone density measurements and their indications. Orthopacle, 23, 38–44.
   PubMed Web of Science ®Google Scholar
• DELMAS, P. D. 1996, Biochemical markers for the assessment of bone turnover. In Osteoporosis: Etiology, Diagnosis and Management, edited by B. L. Riggs and L. J. Melton III (Philadelphia: Lippincott-Raven), pp. 319–333.
   Google Scholar
• DELMAS, P. D., EAsTELL, R., GARNERO, P., SEIBEL, M. J. and STEPAN, J. 2000, The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporosis International, 11 (Suppl. 6), S2—S17.
   Google Scholar
• DOMINGUEZ, C. C., SOSA, H. M., TRABA, M. L, ALVAREZ, V. E. and DE LA PIEDRA, C. 1998, Biochemical markers of bone formation in the study of postmenopausal osteoporosis. Osteoporosis International, 8, 147–151.
   Google Scholar
• HODGES, S. J., AKESSON, K., VERGNAUD, P., OBRANT, K and DELMAS, P. D. 1993, Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. Journal of Bone and Mineral Research, 8, 1241–1245.
   Google Scholar
• ISHLDA, Y. and KAWAL S. 2004, Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. American Journal of Medicine, 117, 549–555.
   Google Scholar
• IWAMOTO, J., TAKEDA, T. and SATO, Y. 2004, Effects of vitamin K2 on osteoporosis. Current Pharmaceutical Design, 10, 2557–2576.
   PubMed Web of Science ®Google Scholar
• KANAI, T, TAKAGI, T, MASUHIRO, K, NAKAMURA, M., IWATA, M. and SAJI, F. 1997, Serum vitamin K level and bone mineral density in post-menopausal women. International Journal of Gynaecology and Obstetrics, 56, 25–30.
   PubMed Web of Science ®Google Scholar
• KANIS, J. A. 1994, Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporosis International, 4, 368–381.
   PubMed Web of Science ®Google Scholar
• KELLER, T., BITIERLICH, N., HILFENHAUS, S., BIGL, H., LOSER, T. and LEONHARDT, P. 1998, Tumourmarkers in the diagnosis of bronchial carcinoma: new options using fuzzy logic-based tumour marker profiles. Journal of Cancer Research and Clinical Oncology, 124, 565–574.
   PubMed Web of Science ®Google Scholar
• MELTON, L. J. III, KHOSLA, S., ATTuNsoN, E. J., O'FAIToN, W. M. and RIGGS, B. L 1997, Relationship of bone turnover to bone density and fractures. Journal of Bone and Mineral Research, 12, 1083–1091.
   Google Scholar
• NORRIS, R J. 1992, Medical costs of osteoporosis. Bone, 13 (Suppl. 2), S11–S16.
   Google Scholar
• PLANTALECH, L., GUILLAUMONT, M., VERGNATJD, P., LECLERCQ, M. and DELMAS, P. D. 1991, Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women. Journal of Bone and Mineral Research, 6, 1211–1216.
   PubMed Web of Science ®Google Scholar
• PREVRHAL, S. and GENANT, H. K 1999, Quantitative computer tomography. Radiologe, 39, 194–202. ROMMEITANGER, H. 1994, Fuzzy Decision Support Systems (Heidelberg: Springer).
   Google Scholar
• RYAN-HARSHMAN, M. and Amoom, W. 2004, Bone health. New role for vitamin K? Canadian Family Physician, 50, 993–997.
   PubMed Web of Science ®Google Scholar
• SCHMOIKE, B. 2001, Laboratory diagnosis of osteoporosis. Orthopacle, 30, 425–436.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ, A. V, KELSEY, J. L., MAGGI, S., TUTTLEMAN, M., Ho, S. C., JoNssoN, P. V, POOR, G., SISSON DE CASTRO, J. A., Xu, L., MATKIN, C. C., NELSON, L M. and HEYSE, S. P. 1999, International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World Health Organization Program for Research on Aging. Osteoporosis International, 9, 242–253.
   PubMed Web of Science ®Google Scholar
• SHEARER, M. J. 1995, Vitamin K. Lancet, 345, 229–234.
   PubMed Web of Science ®Google Scholar
• SHIRAKI, M., SHIRAKI, Y, Amu, C. and MIURA, M. 2000, Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. Journal of Bone and Mineral Research, 15, 515–521.
   PubMed Web of Science ®Google Scholar
• VERMEER, C., JIE, K S. and KNAPEN, M. H. 1995, Role of vitamin K in bone metabolism. Annual Reviews of Nutrition, 15, 1–22.
   PubMed Web of Science ®Google Scholar
• VERMEER, C., THIJSSEN, H. H. W. and HAMULYAK, K 2001, Vitamin K and tissue mineralization. Bibl Nutr DWta, 55, 159–170.
   Google Scholar
• WAT-rs, N. B. 1999, Clinical utility of biochemical markers of bone remodeling. Clinical Chemistry, 45, 1359–1368.
   PubMedGoogle Scholar
• WEILE, U., FINSLER, S., WEHR, U. and CLAUS, R 2001, Comparison of blood markers for the longitudinal monitoring of osteoclastic activity in the pig. Journal of Veterinarian Medicine Series A Physiology Pathology Clinical Medicine, 48, 609–618.
   Google Scholar
• Wrrucan, W. 1996, Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers. European Journal of Clinical Chemistry and Clinical Biochemistry, 34, 785–799.
   PubMedGoogle Scholar